Medicines labeled for the same conditions
Alternatives to dapagliflozin
9 other medicines are given the same way (oral) and in the same FDA class as dapagliflozin or labeled mainly for the same use (chronic kidney disease); 8 are in its class, sodium-glucose cotransporter 2 inhibitors: empagliflozin, canagliflozin and metformin, empagliflozin and metformin, canagliflozin and 4 more; the others include 1 nonsteroidal mineralocorticoid-receptor antagonist (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $5.60 per Synjardy 12.5-1,000 mg tablet (what pharmacies paid in the NADAC survey; strengths differ).
Which medicines are labeled for the same conditions as dapagliflozin?
Chronic kidney disease lists all 8 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (oral) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Dapagliflozinsodium-glucose cotransporter 2 inhibitor | this medicine | 22 labelers | $0.184 per tablet 10 mg tablet | No | No current entry |
| Empagliflozinsodium-glucose cotransporter 2 inhibitor · same class | Heart failure, Type 2 diabetes, Chronic kidney disease | none listed | $11.19 per tablet 10 mg tablet | No | No current entry |
| Canagliflozin and metforminsodium-glucose cotransporter 2 inhibitor · same class | Type 2 diabetes | none listed | $9.58 per tablet 150-1,000 mg tablet | Yes | No current entry |
| Empagliflozin and metforminsodium-glucose cotransporter 2 inhibitor · same class | Type 2 diabetes | none listed | $5.60 per tablet 12.5-1,000 mg tablet | Yes | No current entry |
| Canagliflozinsodium-glucose cotransporter 2 inhibitor · same class | Type 2 diabetes, Chronic kidney disease | none listed | $19.13 per tablet 100 mg tablet | No | No current entry |
| Empagliflozin and linagliptin and metforminsodium-glucose cotransporter 2 inhibitor · same class | Type 2 diabetes | none listed | $11.28 per tablet 10-5-1,000 mg tablet | Yes | No current entry |
| Bexagliflozinsodium-glucose cotransporter 2 inhibitor · same class | Type 2 diabetes | none listed | n/a | No | No current entry |
| Empagliflozin and linagliptinsodium-glucose cotransporter 2 inhibitor · same class | Type 2 diabetes | none listed | $11.24 per tablet 10 mg-5 mg tablet | No | No current entry |
| Sotagliflozinsodium-glucose cotransporter 2 inhibitor · same class | Heart failure | none listed | $20.37 per tablet 200 mg tablet | No | No current entry |
| Finerenonenonsteroidal mineralocorticoid-receptor antagonist | Chronic kidney disease | none listed | $22.86 per tablet 10 mg tablet | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Dapagliflozin: the full record
- label, generics, price, shortages, recalls
- Dapagliflozin vs empagliflozin
- two records side by side